Novel therapeutic targets at the platelet vascular interface

39Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

Platelet activation in vivo can be part of the hemostatic response to injury or a pathological response to disease. In either setting, platelets adhere to the vessel wall and to each other, forming a closely packed mass interspersed with fibrin. Recent studies have identified new molecules on the platelet surface and within platelets that support and regulate thrombus growth and stability, ensuring that platelet accumulation after injury is sufficient to stop bleeding, but not so exuberant that vascular occlusion occurs. An understanding of how this balance is achieved helps to illuminate the events of platelet activation and, at the same time, provides potential targets for new classes of antiplatelet agents. © 2008 American Heart Association, Inc.

Cite

CITATION STYLE

APA

Brass, L. F., Zhu, L., & Stalker, T. J. (2008, March 1). Novel therapeutic targets at the platelet vascular interface. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/ATVBAHA.107.161026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free